KIT and gastrointestinal stromal tumor: The genetic and epigenetic analysis of a low-risk GIST presented here suggests that a typical activating KIT mutation together with loss of one of chromosomes 14 might indeed be sufficient to trigger formation of clinically symptomatic tumours.